BioSpace News Archive

nanoMesh™ LLC, a subsidiary of Exogenesis Corporation, announced today that it has successfully completed filing of a second Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration (FDA) for its first proprietary soft tissue repair device, Exogenesis Hernia Mesh

CSols, Inc. and Abbott Informatics announce a joint webinar to be presented Wednesday April 21, 2021 at 2 PM EDT with Karla Paulson, Senior Project Manager, Abbott Informatics, and Tuan Nguyen, Senior LIMS Consultant, CSols, Inc.

Prognos Health, a leading healthcare analytics platform company, today announced that its proprietary technology FACTOR Logic™ – the lightning-fast data store technology with which the prognosFACTORⓇ platform is built – is now patent pending.

Boosting its leadership pool as it moves into full growth mode, Carmel-based medical device company PathogenX has named tech entrepreneur Jamie Moriarty to its board of directors. The company also announced that former McKesson Corporation sales standout Robert Gurecka has been named National Sales Director and will lead business development, sales and marketing for the company’s North American efforts.

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called “cytokine storm” with its lead drug candidate lenzilumab™, today announced that on April 5, 2021 it completed its underwritten public offering of common stock, resulting in gross proceeds to Humanigen of approximately $92.5 million.

California Protons Cancer Therapy Center announced the treatment of its 3,000th patient with proton therapy since the Center opened in 2014.

Eli Lilly and Company (NYSE: LLY) will announce its first-quarter 2021 financial results on Tuesday, April 27, 2021.

Consumer demand for virtual health care has exploded during the COVID-19 pandemic. Thanks to telemedicine, patients with new concerns and those with chronic conditions can have an appointment with a board-certified physician from the comfort and safety of their homes.

Zero Gravity Solutions, Inc., an agricultural biotechnology company, is expanding upon its previously announced collaboration between its wholly-owned subsidiary, BAM Agricultural Solutions, Inc., and the National Black Farmers’ Association with Dr. John W. Boyd, Jr.

Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced the closing of its previously announced initial public offering in the United States of 9,750,000 American Depositary Shares (“ADSs”) representing 9,750,000 ordinary shares, at an initial public offering price of $18.00 per ADS